Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alkermes Plc (NASDAQ:ALKS)

55.47
Delayed Data
As of Dec 09
 -0.28 / -0.50%
Today’s Change
27.14
Today|||52-Week Range
80.71
-30.12%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$8.4B

Company Description

Alkermes Plc is a biopharmaceutical company. It engages in the development, manufacturing and distribution of medicines. The company was founded on May 4, 2011 and is headquartered in Dublin, Ireland.

Contact Information

Alkermes Plc
Connaught House
Dublin Dublin D04 C5Y6
P:(531) 772-8000
Investor Relations:
(781) 609-6823

Employees

Shareholders

Mutual fund holders69.94%
Other institutional27.59%
Individual stakeholders1.02%

Top Executives

Richard F. PopsChairman & Chief Executive Officer
Shane M. CookePresident
Gordon G. PughSenior VP, Chief Operating & Risk Officer
James M. FratesChief Financial Officer & Senior Vice President
Elliot W. EhrichChief Medical Officer, EVP-Research & Development